02, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the quarter ended September 30, 2017 and updated its full year 2017 financial guidance.
Good morning. My name is Amy and I will be your conference operator today. At this time I would like to welcome everyone to the AMAG Pharmaceuticals' Third Quarter 2017 Earnings Call. All lines have been placed on mute to prevent any background noise.
AMAG Pharmaceuticals Inc. (AMAG) traded on unusually high volume on Oct. 23, as the stock gained 2.88% to close at $16.05. On the day, AMAG Pharmaceuticals Inc. saw 1.59 million shares trade hands on 8,032 trades. Considering that the stock averages ...
AMAG Pharmaceuticals logo Vanguard Group Inc. trimmed its position in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) by 2.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.